(Source: Roche Holding AG) Basel, 5 November 2015 Roche showcases pharmaceuticals strategy and emerging new medicines Launches or pivotal data for up to eight new medicines planned in next three years Focus on strong pipeline of differentiated medicines across a range of therapeutic areas Strategy focused on innovation and advancing treatment in areas of high medical need Efficiency initiatives supporting optimal resource use, R&D productivity and commercial reach Molecular information an emerging key element in Roche’s personalised healthcare strategy Roche (SIX: RO, ROG; OTCQX: RHHBY) is today providing an update on its late-stage pipeline at an investor event in London, including...
↧